Civil Litigation
Feb. 3, 2020
Openings in Roundup cancer trial continued amid settlement rumors
Monsanto, which manufactures the weedkiller, attributed the last minute continuance to “avoid the distractions that can arise from trials.” according to a statement.
A state court trial against Monsanto set to start Friday over claims its Roundup weedkiller causes cancer has been continued as both sides inch toward a settlement.
The Bayer AG-owned company attributed the last-minute continuance to "avoid the distractions that can arise from trials," according to a statement.
Opening statements have not been rescheduled.
A s...
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In